126 related articles for article (PubMed ID: 38697256)
21. Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.
Shammas AN; Jeon-Slaughter H; Tsai S; Khalili H; Ali M; Xu H; Rodriguez G; Cawich I; Armstrong EJ; Brilakis ES; Banerjee S
J Endovasc Ther; 2017 Jun; 24(3):376-382. PubMed ID: 28440113
[TBL] [Abstract][Full Text] [Related]
22. [Report on health status of residents in areas with industrial, mining or military sites in Sardinia, Italy].
Biggeri A; Lagazio C; Catelan D; Pirastu R; Casson F; Terracini B
Epidemiol Prev; 2006; 30(1 Suppl 1):5-95. PubMed ID: 16826748
[TBL] [Abstract][Full Text] [Related]
23. Symptomatic peripheral artery disease increases risk of perioperative mortality following open abdominal aortic aneurysm repair.
Boitano LT; Fan EY; Crawford AS; Tanious A; Jones D; Simons JP; Schanzer A
J Vasc Surg; 2023 Aug; 78(2):370-377. PubMed ID: 37088442
[TBL] [Abstract][Full Text] [Related]
24. Temporal trends in the management and clinical outcomes of lower extremity arterial thromboembolism within a national Veteran population.
Prouse AF; Langner P; Plomondon ME; Ho PM; Valle JA; Barón AE; Armstrong EJ; Waldo SW
Vasc Med; 2019 Feb; 24(1):41-49. PubMed ID: 30105938
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study.
Vidula H; Tian L; Liu K; Criqui MH; Ferrucci L; Pearce WH; Greenland P; Green D; Tan J; Garside DB; Guralnik J; Ridker PM; Rifai N; McDermott MM
Ann Intern Med; 2008 Jan; 148(2):85-93. PubMed ID: 18195333
[TBL] [Abstract][Full Text] [Related]
26. Systematic review and meta-analysis of outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end-stage renal disease.
Anantha-Narayanan M; Sheikh AB; Nagpal S; Jelani QU; Smolderen KG; Regan C; Ionescu C; Ochoa Chaar CI; Schneider M; Llanos-Chea F; Mena-Hurtado C
J Vasc Surg; 2021 Jan; 73(1):331-340.e4. PubMed ID: 32889074
[TBL] [Abstract][Full Text] [Related]
27. Mortality-Air Pollution Associations in Low Exposure Environments (MAPLE): Phase 2.
Brauer M; Brook JR; Christidis T; Chu Y; Crouse DL; Erickson A; Hystad P; Li C; Martin RV; Meng J; Pappin AJ; Pinault LL; Tjepkema M; van Donkelaar A; Weagle C; Weichenthal S; Burnett RT
Res Rep Health Eff Inst; 2022 Jul; 2022(212):1-91. PubMed ID: 36224709
[TBL] [Abstract][Full Text] [Related]
28. Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease.
Urbonaviciene G; Martin-Ventura JL; Lindholt JS; Urbonavicius S; Moreno JA; Egido J; Blanco-Colio LM
Atherosclerosis; 2011 Dec; 219(2):892-9. PubMed ID: 21962403
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Visit-to-Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes.
Hsu JC; Yang YY; Chuang SL; Huang KC; Lee JK; Lin LY
J Am Heart Assoc; 2023 Feb; 12(3):e025438. PubMed ID: 36695326
[TBL] [Abstract][Full Text] [Related]
30. The dynamics of mortality in follow-up time after an acute myocardial infarction, lower extremity arterial disease and ischemic stroke.
Vaartjes I; van Dis I; Grobbee DE; Bots ML
BMC Cardiovasc Disord; 2010 Nov; 10():57. PubMed ID: 21106115
[TBL] [Abstract][Full Text] [Related]
31. Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD.
Hess CN; Debus ES; Nehler MR; Anand SS; Patel MR; Szarek M; Capell WH; Hsia J; Beckman JA; Brodmann M; Diaz R; Habertheuer P; Leeper NJ; Powell RJ; Sillesen H; Muehlhofer E; Berkowitz SD; Haskell LP; Bauersachs RM; Bonaca MP
Circulation; 2021 Dec; 144(23):1831-1841. PubMed ID: 34637332
[TBL] [Abstract][Full Text] [Related]
32. The Nevada peripheral artery disease screening effort in a Medicare Advantage population and subsequent mortality and major adverse cardiovascular event risk.
Smolderen KG; Heath K; Scherr T; Bauzon SR; Howell AN; Mena-Hurtado C
J Vasc Surg; 2022 Jun; 75(6):2054-2064.e3. PubMed ID: 35181520
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization.
Stone PA; Schlarb H; Campbell JE; Williams D; Thompson SN; John M; Campbell JR; AbuRahma AF
J Vasc Surg; 2014 Sep; 60(3):652-60. PubMed ID: 24795153
[TBL] [Abstract][Full Text] [Related]
34. Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative.
Siracuse JJ; Menard MT; Eslami MH; Kalish JA; Robinson WP; Eberhardt RT; Hamburg NM; Farber A;
J Vasc Surg; 2016 Apr; 63(4):958-65.e1. PubMed ID: 26830690
[TBL] [Abstract][Full Text] [Related]
35. Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery Disease.
Weissler EH; Narcisse DI; Rymer JA; Armstrong EJ; Secemsky E; Gray WA; Mustapha JA; Adams GL; Ansel GM; Patel MR; Jones WS
Vasc Endovascular Surg; 2021 Feb; 55(2):124-134. PubMed ID: 33094679
[TBL] [Abstract][Full Text] [Related]
36. Temporal Changes in Secondary Prevention and Cardiovascular Outcomes After Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
Søgaard M; Nielsen PB; Skjøth F; Eldrup N; Larsen TB
Circulation; 2021 Mar; 143(9):907-920. PubMed ID: 33300375
[TBL] [Abstract][Full Text] [Related]
37. Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial.
Anand SS; Caron F; Eikelboom JW; Bosch J; Dyal L; Aboyans V; Abola MT; Branch KRH; Keltai K; Bhatt DL; Verhamme P; Fox KAA; Cook-Bruns N; Lanius V; Connolly SJ; Yusuf S
J Am Coll Cardiol; 2018 May; 71(20):2306-2315. PubMed ID: 29540326
[TBL] [Abstract][Full Text] [Related]
38. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
[TBL] [Abstract][Full Text] [Related]
39. Sex differences in the outcomes of peripheral arterial disease: a population-based cohort study.
Hussain MA; Lindsay TF; Mamdani M; Wang X; Verma S; Al-Omran M
CMAJ Open; 2016; 4(1):E124-31. PubMed ID: 27280110
[TBL] [Abstract][Full Text] [Related]
40. History of lower-limb complications and risk of cancer death in people with type 2 diabetes.
Mohammedi K; Harrap S; Mancia G; Marre M; Poulter N; Chalmers J; Woodward M
Cardiovasc Diabetol; 2021 Jan; 20(1):3. PubMed ID: 33397352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
